PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
28-Oct-2024 Duhn Therapeutics, launched by Landmark BioVentures, signs global license agreement with OM Pharma to further advance clinical-stage, lipid-based cancer immunotherapy Duhn Therapeutics
28-Oct-2024 CluePoints Appoints Richard Young as Chief Strategy Officer CluePoints
28-Oct-2024 2nd Global Summit on Vaccines and Immunology(GSVI2025) Apex Global Meetings
23-Oct-2024 Ten businesses embark on Discovery Park’s ‘Discovery Spark’ programme Discovery Park
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech Innovate UK
23-Oct-2024 ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares ProQR Therapeutics
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics N.V.
23-Oct-2024 4Tissue Raises €2M to Advance Groundbreaking Breast Tissue Replacement Technology 4Tissue
23-Oct-2024 Capital Markets Event 2024: Lundbeck to showcase progress on Focused Innovator Strategy driving sustainable long-term growth H. Lundbeck A/S
23-Oct-2024 DARZALEX® (daratumumab)-SC based quadruplet regimen approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible Janssen-Cilag International NV
23-Oct-2024 Biocartis announces six Idylla™ abstracts to be presented at AMP 2024 Annual Meeting Biocartis NV
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics
23-Oct-2024 Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset Angelini Pharma
23-Oct-2024 LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR DONANEMAB (KISUNLA ®▼) FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER’S DISEASE IN ADULT PATIENTS WHO ARE APOLIPOPROTEIN E ε4 HETEROZYGOTES OR NON-CARRIERS Eli Lilly and Company Limited
23-Oct-2024 OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain OKYO Pharma Limited
22-Oct-2024 ICR HEALTHCARE LAUNCHES AS A UNIFIED GLOBAL BRAND IN HEALTHCARE STRATEGIC COMMUNICATIONS AND INVESTOR RELATIONS ICR
22-Oct-2024 Biodiversity is fundamental to feed a hungry planet - IFAD at COP16 Colombia International Fund for Agricultural Development (IFAD)
22-Oct-2024 Quell Therapeutics to Present Promising Data from Autologous and Allogenic CAR-Treg Programs at Upcoming International Congresses Quell Therapeutics
22-Oct-2024 Wobble Genomics Presents Novel Early Detection Technology Demonstrating Exceptional Accuracy in Early-Stage Breast Cancer Wobble Genomics
22-Oct-2024 NICE recommends Voydeya® (danicopan) with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria (PNH) in adults with residual haemolytic anaemia AstraZeneca